AACR-NCI-EORTC International Conference (ENA) 2024, October 23-25, 2024

Assets in this page

Download assets

• pdf file

  Phase I/II trial of RVU120, a CDK8/CDK19 inhibitor in patients with relapsed/refractory metastatic or advanced solid tumors

  Download
• pdf file

  Discovery of novel MTA-cooperative PRMT5 preclinical candidate as targeted therapeutics for MTAP-deleted cancers

  Download
• pdf file

  Discovery of WRN inhibitors as targeted therapy in the treatment of microsatellite unstable (MSI-H) tumors

  Download
• pdf file

  Exploring Synthetic Lethality and Novel Drug Combinations in Patient-Derived Cells

  Download